Starboard Value, the activist investor pushing for changes at Pfizer, unveiled its goals for another healthcare company — Johnson & Johnson’s consumer spinout Kenvue.
In a …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Patients with high-risk gastrointestinal stromal tumors (GISTs) had a 60% improvement in 3-year disease-free survival (DFS) with 6 versus 3 years of maintenance imatinib, a
The FDA granted accelerated approval to eladocagene exuparvovec (Kebilidi) to treat children and adults with aromatic L-amino acid decarboxylase (AADC) deficiency, the agency announced Thursday.
Keith Jones, CIO at Cone Health What You Should Know: – Keith Jones has been appointed as the permanent chief information officer (CIO) at Cone